Interpace Biosciences Inc ROCE
¿Qué es el ROCE de Interpace Biosciences Inc?
El ROCE de Interpace Biosciences Inc es -30.89%
¿Cuál es la definición de ROCE?
El retorno sobre el capital empleado (ROCE) es una relación financiera que mide la rentabilidad de una empresa y la eficiencia con la que se utiliza su capital.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE de compañías en Sector Health Care en NASDAQ en comparadas con Interpace Biosciences Inc
¿Qué hace Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Empresas con roce similar a Interpace Biosciences Inc
- OBITX tiene ROCE de -30.96%
- Vistagen Therapeutics tiene ROCE de -30.93%
- TOMI Environmental Solutions tiene ROCE de -30.93%
- Medicenna Therapeutics tiene ROCE de -30.92%
- InfraStrata Plc tiene ROCE de -30.92%
- Antibe Therapeutics tiene ROCE de -30.90%
- Interpace Biosciences Inc tiene ROCE de -30.89%
- Provexis plc tiene ROCE de -30.88%
- KRM22 Plc tiene ROCE de -30.87%
- Treasure ASA tiene ROCE de -30.86%
- Germinate Capital tiene ROCE de -30.81%
- Boxlight tiene ROCE de -30.77%
- Duke Offshore tiene ROCE de -30.75%